April 23, 2015;  Andrew Skodyn

In a rare and surprising turn of events, a full panel of the Supreme Court of Canada unanimously dismissed Sanofi-Aventis' appeal of its "Section 8" liability at the conclusion of oral argument on April 20. (Sanofi-Aventis v. Apotex Inc., 2015 SCC 20).

February 27, 2015

A decision issued last month contains a useful synopsis by Justice Zinn of principles applicable to damages awards in patent infringement cases: Eli Lilly & Co. et al. v. Apotex Inc. 2014 FC 1254.

September 18, 2014;  Paul-Erik Veel

The British Columbia Supreme Court's decision in Low v. Pfizer Canada Inc., 2014 BCSC 1469 could radically change the legal landscape for patent law in Canada. Patent law has thus far been entirely statutory rather than a product of the common law; courts had not recognized any common law rights or remedies in relation to patents. The decision of Justice Smith changes that, and in so doing...